Jim Cunningham

Jim Cunningham is the current Executive Director of Early & Late Phase Clinical Business Development at QPS. Jim has over 12 years of experience in the field, and has held various positions at QPS Holdings, LLC during that time, including Executive Director of Early Phase Clinical Business Development, Global Head of Early Phase Clinical Business Development, and Senior Director of Business Development. In each of these positions, Jim was responsible for managing the growth and customer relationships for QPS Early Phase Clinical services globally. Jim oversaw the global Early Phase Clinical business development team and was responsible for QPS's growth in total revenue every year.

QPS is a Global GLP/GCP-compliant contract research organization (CRO) supporting discovery, preclinical and clinical drug development. Services include- Tox, Preclinical and clinical drug metabolism and pharmacokinetics (DMPK), Bioanalysis, Early and Late clinical research and Translational medicine from our facilities in the US, Europe and Asia. Jim's experience in managing the growth and customer relationships for QPS Early Phase Clinical services globally makes him uniquely qualified to lead the company's business development efforts.